Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Liabilities and Shareholders Equity (2024 - 2025)

Historic Liabilities and Shareholders Equity for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $6.7 million.

  • Kairos Pharma's Liabilities and Shareholders Equity changed N/A to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Kairos Pharma's Liabilities and Shareholders Equity stood at $6.7 million.
  • In the past 5 years, Kairos Pharma's Liabilities and Shareholders Equity registered a high of $7.9 million during Q1 2025, and its lowest value of $5.0 million during Q3 2024.